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A Homozygous Nonsense Mutation in the Zinc-Finger
Domain of the Human Hairless Gene Underlies Congenital
Atrichia
To the Editor:
Congenital atrichia (OMIM 209500) is a rare form of total alopecia
and is inherited in an autosomal recessive pattern (Burke, 1954;
Landes and Langer, 1956; Ahmad et al, 1993, 1998a, b, 1999;
Zlotogorski et al, 1998). In individuals affected with this form of
hair loss, hairs are typically absent from the scalp, and patients are
almost completely devoid of eyebrows, eyelashes, axillary, and
pubic hair. A scalp skin biopsy from affected individuals typically
reveals the absence of mature hair follicle structures. Variations in
the structure and shape of hair follicle remnants have been reported
in patients with congenital atrichia. These include shortened
hair follicles containing horny plugs, and a reduced number of
pilosebaceous units containing malformed hairs without cuticles
(Porter, 1973). Affected individuals show no growth or develop-
mental delay, have normal hearing, teeth, and nails, and no
abnormalities in sweating. Congenital atrichia affects males and
females equally, from all ethnic backgrounds.
We and others (Ahmad et al, 1998a; Nothen et al, 1998) recently
reported a linkage in this form of atrichia to chromosome 8p12,
and we identified the human homolog of the hairless gene in the
same region of chromosome 8 (Ahmad et al, 1998a). More recently,
we have identified pathogenic missense and deletion mutations in
the human hairless gene in this form of atrichia in families
from Pakistan, Ireland, and Israel (Ahmad et al, 1998a, b, 1999;
Zlotogorski et al, 1998). As an extension of these studies, here we
studied a family from Japan with a single member affected with
congenital atrichia, whose clinical history was described in detail
earlier by Nomura and Hashimoto (1998). Briefly, the proband
was born with normal hair, which began to shed at the age of 6
mo and progressed to complete hairlessness at the age of 1 y. Hair
was absent from the scalp, axillae, pubis, and other parts of the
body, and eyebrows and eyelashes were sparse. She had the
additional characteristics features of grouped cystic and papular
lesions on the neck, buttocks, and thighs. A skin biopsy from the
neck showed deep dermal keratinous cysts. The patient exhibited
no other physical, developmental, or neuropsychologic abnormality.
The family pedigree is strongly suggestive of autosomal recessive
inheritance (Fig 1a).
To search for an underlying mutation in the hairless gene,
genomic DNA was isolated from peripheral blood collected in
EDTA-containing tubes according to standard techniques
(Sambrook et al, 1989). Exons and splice junctions were polymerase
chain reaction amplified from genomic DNA and sequenced
directly in an ABI Prism 310 Automated Sequencer, using the ABI
Prism Rhodamine Terminator Cycle Sequencing Ready Reaction
Sequencing Kit (PE Applied Biosystems, Foster City, CA), follow-
ing purification in a Centriflex Gel Filtration Cartridge (Edge
Biosystems, Gaithersburg, MD). A 287 bp polymerase chain reaction
fragment containing exon 6 of the human hairless gene was
amplified using primers described earlier (Ahmad et al, 1998b).
Sequence analysis of exon 6 revealed a C-to-T transition at
nucleotide position 1837 (Fig 1b), resulting in the conversion of
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an arginine to a premature termination codon, designated R613X.
This mutation is predicted to result in the absence of mRNA
and functional protein, due to nonsense-mediated mRNA decay
(Maquat, 1996).
Recently, we have reported missense and deletion mutations in
the human hairless gene in families from Pakistan, Ireland, and
Israel with congenital atrichia (Ahmad et al, 1998a, b; Zlotogorski
et al, 1998; Ahmad et al, 1999). In this study, we report the
identification of a nonsense mutation in the highly conserved zinc-
finger DNA binding domain of the gene in a family from Japan.
In our previous study, we reported a missense mutation (R620Q)
in the zinc-finger domain of the hairless gene in a large family of
Irish travellers from Ireland (Ahmad et al, 1998b), suggesting that
mutations tend to cluster in the zinc-finger domain of the gene, as
shown in our analysis of hairless and rhino mouse mutations
(Ahmad et al, 1998c, d; Panteleyev et al, 1998a). The phenotypic
appearance of the proband in this family is reminiscent of our
previous cases, as well as those reported earlier (Burke, 1954;
Landes and Langer, 1956; Cantu et al, 1980), including atrichia
with cystic papules on the elbows and knees. As early as 1954, this
rare human disease was named atrichia with papular lesions, and
was characterized as normal hair formation at birth followed by
hair loss associated with the formation of comedones and follicular
cysts (Damste and Prakken, 1954; Landes and Langer, 1956;
Lowenthal and Prakken, 1961; Del Castillo et al, 1974; Cantu et al,
1980; Kanzler and Rasmussen, 1986; Rook and Dawber, 1991;
Misciali et al, 1992). In 1989, the human disease was first proposed
as a homolog of the hairless mouse mutation (Sundberg et al, 1989).
The molecular basis of the hairless mouse phenotype was
previously found to be the result of a murine leukemia proviral
insertion in intron 6 of the hairless gene, reported to result in
aberrant splicing (Cachon-Gonzalez et al, 1994). In addition, we
recently reported a series of nonsense and deletion mutations in
the hairless mice gene in the rhino mice, which were known to
be allelic to hairless mice (Ahmad et al, 1998c, d; Panteleyev et al,
1998a). The hairless protein is a putative transcription factor with
a single zinc-finger domain, which is highly expressed in the brain
and the skin. The hairless gene contains a single zinc-finger DNA
binding domain with a novel spacing of a conserved six-cysteine
motif, and only weak homology to two classes of genes: TSGA, a
testes-specific transcription factor, and TRIPs, thyroid hormone
interacting proteins (Ahmad et al, 1999). Despite the high levels of
hairless expression in the brain as compared with skin, neither
hairless nor rhino mice display any neurologic, behavioral, or
developmental defects whatsoever. This finding correlates well with
human patients with atrichia, in whom we have also never observed
these sequelae. We have, however, observed a striking genotype–
phenotype relationship between hairless and rhino mice with
respect to the severity of the disease phenotype in the hair and
skin. The hairless proviral insertion mutation results in a moderate
hairless phenotype; however, the nonsense and deletion mutations
in rhino mice result in a much more profound and accelerated
phenotype (Ahmad et al, 1998c, d; Panteleyev et al, 1998a).
Surprisingly, we have not observed this genotype-phenotype rela-
tionship in our human patients with atrichia. We have identified two
missense and two deletion mutations thus far, with indistinguishable
clinical findings. The Japanese patient in this study represents the
first nonsense mutation in the hairless gene in an atrichia patient,
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Figure 1. Genetic analysis of atrichia family. (A) Pedigree representing a Japanese family with a single member affected with congenital atrichia.
Circles and squares represent females and males, respectively. The filled circle represents the proband (individual V-2). The dots within figures represent
obligate heterozygote carriers, and the numbers within circles and squares indicate the number of female and male offspring, respectively. Diagonal slashes
are indicative of deceased individuals, and the diamond in generation VI is indicative of four miscarried pregnancies from individual V-2. (B) Automated
DNA sequence analysis of the hairless gene mutation. DNA sequence of exon 6 of the hairless gene is shown from control and affected individual. The
arrow denotes nucleotide position 1837 in the hairless cDNA.
and similar to the earlier reports, the phenotype is identical. Why
we observe a marked genotype–phenotype correlation in mice but
not humans with atrichia is currently under investigation.
The precise function of hairless protein remains elusive;
however, recent studies have established that hairless functions
as a transcriptional corepressor in the brain, and is regulated
directly by thyroid hormone (Thompson, 1996; Thompson and
Bottcher, 1997). In the hair follicle, it appears to function in
the cellular transition to the first adult hair cycle, and in its
absence hair growth completely ceases, a new hair is never
induced, and the result is a complete form of inherited alopecia.
The hair matrix cells undergo a premature and massive apoptosis,
together with a concomitant decline in Bcl-2 expression, a loss
of NCAM positivity, and a disconnection with the overlying
epithelial sheath essential for the movement of the dermal papilla
(Panteleyev et al, 1998b, c). As a consequence, the hair bulb
and dermal papilla remain stranded in the dermis, and indispensable
messages between the dermal papilla and stem cells in the bulge
are not transmitted, thus no further hair growth occurs. In
hairless mice and humans with congenital atrichia, we postulate
that the absence of hairless protein initiates a premature and
abnormal catagen due to abnormal signaling that normally control
catagen-associated hair follicle remodeling (Panteleyev et al,
1998c, d). These findings suggest that the hairless gene product
may play a crucial role in maintaining the balance between cell
proliferation, differentiation, and apoptosis in the hair follicle as
well as in the interfollicular epidermis.
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UV Induces p21WAF1/CIP1 Protein in Keratinocytes Without p53
To the Editor:
A central effect of UV in the skin is to arrest the cell cycle in
G1 and S phase (Epstein et al, 1970; Petrocelli et al, 1996).
p21WAF1/CIP1, a cyclin-dependent kinase inhibitor, is induced in
cultured keratinocytes and in human skin following UV irradiation
(Liu and Pelling, 1995; Ponten et al, 1995; Petrocelli et al,
1996). Induction of this protein is known to mediate G1 and
S phase arrest by inhibiting cdk2 and cdk4 kinases (Petrocelli
et al, 1996; Poon et al, 1996). p21WAF1/CIP1 also blocks DNA
replication by interacting with proliferating-cell nuclear antigen
(PCNA) (Li et al, 1994). In addition, recent evidence suggests
that it facilitates repair of UV-induced DNA photoproducts
(Sheikh et al, 1997). p21WAF1/CIP1 was first identified as a p53-
inducible gene (El-Deiry et al, 1993); the tumor suppressor p53
is also known to play an important role in the UV response
(Lane, 1992; Ziegler et al, 1994). Although p21WAF1/CIP1 mRNA
induction by DNA-damaging agents typically requires p53
(El-Deiry et al, 1994; Macleod et al, 1995), p21WAF1/CIP1 can
also be regulated during normal tissue development and cellular
differentiation without p53 (Macleod et al, 1995). In this study,
we investigated whether UV induction of p21WAF1/CIP1 protein
in keratinocytes requires p53 in vivo and in vitro.
We first took advantage of the recent availability of a
p21WAF1/CIP1 antibody effective in paraffin sections of mouse
skin, and studied p21WAF1/CIP1 protein expression in vivo.
Figure 1 shows that there was detectable p21WAF1/CIP1 expression
in unirradiated keratinocytes of wild-type p53 mice, but minimal
basal expression in p53-knockout mice. This is consistent with
previous evidence that p53 may be required to control the
expression of p21WAF1/CIP1 during keratinocyte differentiation
(Weinberg et al, 1994; Missero et al, 1996). At 24 h post-UV-
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irradiation, p21WAF1/CIP1 protein levels were elevated in epidermal
keratinocytes of the wild-type p53 mouse, as expected. Strikingly,
however, p21WAF1/CIP1 induction by UV occurred to an
apparently equal extent in the keratinocytes of p53-deficient mice.
The observation of p21WAF1/CIP1 induction by UV without
p53 was unexpected, since other DNA-damaging agents elevate
p21WAF1/CIP1 in a p53-dependent manner in vitro (El-Deiry et al
1994; Macleod et al, 1995). To exclude an in vivo/in vitro
difference, we next investigated whether, in vitro, UV induces
p21WAF1/CIP1 protein without p53. Figure 2 shows that UV
induced the p21 protein level in murine p53-null NHK4
keratinocytes (Azzoli et al, 1998) at 40 J per m2 and 120 J per
m2. In addition, p21WAF1/CIP1 mRNA expression was upregulated
by UV at 120 J per m2, though not at 40 J per m2. Murine
p53-deficient (10)1 fibroblasts (Harney and Levine, 1991) behaved
similarly (data not shown).
We here provide evidence that UV, the DNA-damaging agent
most relevant to skin, can induce p53-independent p21WAF1/
CIP1 protein expression in keratinocytes in vivo and in vitro. This
observation may have implications for skin’s protection against
basal and squamous cell carcinoma. When keratinocytes are
damaged by UV, the p53 tumor suppressor is known to offer
protection by inducing cell cycle arrest (‘‘guardian-of-the-
genome’’) and apoptosis (‘‘guardian-of-the-tissue’’) (Lane, 1992;
Hall et al, 1993; Liu et al, 1994; Ziegler et al, 1994); however,
the p53 gene is itself a target of UV radiation. UV-induced p53
mutations have been found in most human skin cancers, in skin
precancers (actinic keratoses), and in 20% of keratinocytes in
sun-exposed skin (Jonason et al, 1996; Ziegler et al, 1994). In
contrast, there are few p21WAF1/CIP1 mutations in human skin
cancers (our unpublished results) or other malignancies (Shiohara
et al, 1994). Therefore, p21WAF1/CIP1 induction by UV in the
absence of p53 may compensate for the loss of p53 functions
by nevertheless initiating cell cycle arrest, inhibiting DNA
replication, and facilitating DNA repair.
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